Frazier Life Sciences Management, L.P.

13F Filings History

Latest 13F report
Q3 2024 - Nov 15, 2024
Value $
$2.5B
Signature - Title
Steve R. Bailey - Chief Financial Officer and Chief Compliance Officer
Location
Palo Alto, CA
Summary
This page shows a list of all the recent 13F filings made by Frazier Life Sciences Management, L.P.. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Frazier Life Sciences Management, L.P. reported 53 stock holdings with total value $2.5B as of Q3 2024. Top holdings included MIRM, NAMS, PHAT, KRYS, and MBX.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q3 2024 53 $2.5B +$288M -$85.1M +$203M MIRM, NAMS, PHAT, KRYS, MBX 13F-HR 11/15/2024, 07:41 AM
Q2 2024 49 $2.14B +$258M -$322M -$64M NAMS, MIRM, KRYS, HLVX, PHAT 13F-HR 8/15/2024, 12:49 PM
Q1 2024 50 $2.37B +$230M -$107M +$123M NAMS, KRYS, MIRM, HLVX, ALPN 13F-HR 5/15/2024, 12:00 PM
Q4 2023 49 $1.87B +$156M -$85M +$70.6M MIRM, HLVX, NAMS, KRYS, BBIO 13F-HR 2/14/2024, 01:55 PM
Q3 2023 51 $1.5B +$238M -$250M -$11.7M MIRM, HLVX, KRYS, NAMS, PHAT 13F-HR 11/14/2023, 01:40 PM
Q2 2023 48 $1.67B +$153M -$80.1M +$72.6M HLVX, KDNY, PHAT, NAMS, KRYS 13F-HR 8/14/2023, 09:48 AM
Q1 2023 49 $1.38B +$109M -$171M -$62.1M HLVX, NAMS, KDNY, ARQT, MIRM 13F-HR 5/15/2023, 12:41 PM
Q4 2022 44 $1.61B +$227M -$39.6M +$188M HLVX, IMGO, ARQT, KDNY, NAMS Restatement 2/7/2023, 02:30 PM
Q3 2022 43 $1.27B +$201M -$74.6M +$127M HLVX, ARQT, PHAT, KDNY, SNDX 13F-HR 11/14/2022, 10:29 AM
Q2 2022 41 $1.04B +$148M -$179M -$30.5M ARQT, HLVX, KRYS, MIRM, KDNY 13F-HR 8/10/2022, 03:07 PM
Q1 2022 42 $1.17B $0 $0 ARQT, PHAT, MIRM, SRRA, KRYS 13F-HR 5/13/2022, 07:15 PM